Urine Biopsy Detects Biomarkers, Drug Targets in Prostate Cancer
Tissue biopsies to diagnose prostate cancer are invasive and they often miss cancer cells, which limits their utility for diagnosis.
Urine Biopsy Detects Biomarkers, Drug Targets in Prostate Cancer
Tissue biopsies to diagnose prostate cancer are invasive and they often miss cancer cells, which limits their utility for diagnosis.
Urine Biopsy Detects Biomarkers, Drug Targets in Prostate Cancer
Tissue biopsies to diagnose prostate cancer are invasive and they often miss cancer cells, which limits their utility for diagnosis.
Fewer Prostate Biopsies After USPSTF Limited PSA Screening
Following the 2012 USPSTF recommendation against PSA screening in populations, rates of radical prostatectomy and biopsy have become significantly less common.
Urinary, Sexual Function Recovery Differs by Localized PCa Treatment
Urinary, bowel, sexual function, and quality of life among men with prostate cancer may vary depending on treatment type.
Long-term ADT Use Not Linked With Cognitive Decline
Ongoing use of androgen-deprivation therapy (ADT) for up to 36 months is not associated with cognitive decline among men with prostate cancer.
Androgen Suppression With Salvage Radiotherapy May Fight Progression
Adding short-term androgen suppression to salvage radiotherapy may benefit men with prostate cancer who have undergone radical prostatectomy.
RP Linked With Favorable Outcomes in PCa Patients Considered Low Risk
Men with low-risk prostate cancer who undergo open or robot-assisted radical prostatectomy may have favorable oncological outcomes.
Low Testosterone After ADT Linked with Improved Survival
Low serum testosterone levels within the first year of androgen-deprivation therapy (ADT) is associated with improved cause-specific survival.
Insulin Resistance Linked to High Phosphorus in Maintenance Hemodialysis (MHD) Patients
In adjusted analyses, serum phosphorus levels independently predicted glucose disposal rate.
- Loading...
Loading...
Next post in Kidney Week 2014 Hyperphosphatemia
Loading... 
Loading...